A Robust, High-Titer, Semi-Automated, and In-Culture Antibody-Capturing Transient CHO Platform Technology
This new production platform was proven to be robust and could be applied for the routine production of antibodies of sufficient quality and quantity in support of cell-based assays and biophysical characterization.
Authors
- Ade Fatai Adeniyi (ORCID: https://orcid.org/0000-0002-9083-0539)
- Molica Abel
- Laura Lin (ORCID: https://orcid.org/0000-0003-1619-7437)
- Xiaotian Zhong (ORCID: https://orcid.org/0000-0002-7505-6485)
- Bo Hee Shin (ORCID: https://orcid.org/0000-0001-8790-7382)
- Will Somers
- Aaron M. D’Antona (ORCID: https://orcid.org/0000-0003-0063-5594)
- Guoying Yan
- Jing Wen Zhou (ORCID: https://orcid.org/0000-0001-8336-7278)
- Florian Μ. Wurm (ORCID: https://orcid.org/0000-0003-1114-4520)
- Ana Luísa Santos (ORCID: https://orcid.org/0000-0001-5918-0577)
- L. P. Gebhardt
- A Vogt
- Sean K. H. Lim
- Sarah L. Herrick Wagman
- Jerome Puginier
Institutions
- Pfizer (United States) (US)
- Biocant (PT)
- DiagnoSwiss (Switzerland) (CH)
- École Polytechnique Fédérale de Lausanne (CH)
Publication Details
- Journal
- Antibodies
- Published
- 2025-10-11
- DOI
- https://doi.org/10.3390/antib14040087
- Primary Topic
- Viral Infectious Diseases and Gene Expression in Insects
- Type
- article
- Field-Weighted Citation Impact
- 0.00